Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Nov 2;18(11):e0293529.
doi: 10.1371/journal.pone.0293529. eCollection 2023.

Treatment outcomes of cutaneous leishmaniasis due to Leishmania aethiopica: A systematic review and meta-analysis

Abebaw Yeshambel Alemu  1   2   3 , Lemma Derseh  2 , Mirgissa Kaba  4 , Endalamaw Gadisa  3 , Kassahun Alemu  2
Affiliations
Meta-Analysis

Treatment outcomes of cutaneous leishmaniasis due to Leishmania aethiopica: A systematic review and meta-analysis

Abebaw Yeshambel Alemu et al. PLoS One. .

Abstract

Background: Leishmania aethiopica is a unique species that causes cutaneous leishmaniasis (CL), and studies evaluating treatment outcomes for this condition reported inconsistent findings. This study aimed to summarize the evidence on treatment outcomes of CL caused by L. aethiopica to support decisions or propose further study.

Methods: We searched PubMed, Scopus, and ScienceDirect. In addition, we searched grey literature on Google Scholar and performed manual searching on the reference list of articles. Two authors did the screening, selection, critical appraisal, and data extraction. With the narrative synthesis of evidence, we performed a random effects model meta-analysis using the metaprop package in Stata 17. We did sensitivity and subgroup analyses after assessing heterogeneity using the I-squared test and forest plots. The funnel plot and Egger's test were used to assess publication bias.

Results: The review included 22 studies with 808 participants, and the meta-analysis included seven studies with 677 participants. Most studies documented treatment outcomes with antimonial monotherapy, and only one study reported outcomes with combination therapy. The overall pooled proportion of cure was 63% (95% CI: 38-86%). In the subgroup analysis, systemic antimonial monotherapy showed a cure rate of 61%, and the proportion of cure was 87% with topical therapy. Topical therapy showed a better cure for the localized clinical phenotype. A cohort study documented a cure rate of 94.8% with combination therapy for the localized, mucocutaneous, and diffuse clinical phenotypes. The pooled proportion of unfavourable outcomes was partial response (19%), relapse (17%), discontinuation (19%), and unresponsiveness (6%).

Conclusions: The pooled proportion of cure is low with antimonial monotherapy. Despite limited evidence, combination therapies are a promising treatment option for all clinical phenotypes of CL caused by L. aethiopica. Future high-quality randomized control trials are needed to identify effective monotherapies and evaluate the effectiveness of combination therapies.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The PRISMA flow diagram.
Fig 2
Fig 2. Funnel plot.
Fig 3
Fig 3. Forest plot of the pooled proportion of CL treatment cure.
Fig 4
Fig 4. Subgroup analysis forest plot of treatment cure by study design.
Fig 5
Fig 5. Subgroup analysis forest plot of treatment cure by treatment type.
Fig 6
Fig 6. Subgroup analysis forest plot of treatment cure by clinical phenotype.
Fig 7
Fig 7. Sensitivity analysis.
See this image and copyright information in PMC

References

    1. de Vries HJC, Schallig HD. Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments. Am J Clin Dermatol. 2022;23(6):823–40. doi: 10.1007/s40257-022-00726-8 - DOI - PMC - PubMed
    1. Akilov OE, Khachemoune A, Hasan T. Clinical manifestations and classification of Old World cutaneous leishmaniasis. International journal of dermatology. 2007;46(2):132–42. doi: 10.1111/j.1365-4632.2007.03154.x - DOI - PubMed
    1. van Henten S, Adriaensen W, Fikre H, Akuffo H, Diro E, Hailu A, et al.. Cutaneous leishmaniasis due to Leishmania aethiopica. EClinicalMedicine. 2018;6:69–81. doi: 10.1016/j.eclinm.2018.12.009 - DOI - PMC - PubMed
    1. Lemma W, Erenso G, Gadisa E, Balkew M, Gebre-Michael T, Hailu A. A zoonotic focus of cutaneous leishmaniasis in Addis Ababa, Ethiopia. Parasites & vectors. 2009;2(1):60. doi: 10.1186/1756-3305-2-60 - DOI - PMC - PubMed
    1. McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJM: An International Journal of Medicine. 2013;107(1):7–14. doi: 10.1093/qjmed/hct116 - DOI - PMC - PubMed

Publication types